HCG (hear.com NV) YoY EBITDA Growth: -56.67% (As of Mar. 2021)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is hear.com NV YoY EBITDA Growth?

hear.com NV HCG YoY EBITDA Growth is -56.67% as of Mar. 2021.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. hear.com NV's YoY EBITDA Growth for the quarter that ended in Mar. 2021 was -56.67%.

hear.com NV's EBITDA per Share for the three months ended in Mar. 2021 was $-0.05.

hear.com NV YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for hear.com NV's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

hear.com NV YoY EBITDA Growth Chart

hear.com NV Annual Data
Trend Sep18 Sep19 Sep20
YoY EBITDA Growth
0.00 0.00 -26.44

hear.com NV Quarterly Data
Sep19 Dec19 Mar20 Sep20 Dec20 Mar21
YoY EBITDA Growth Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 -56.67

hear.com NV YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

hear.com NV's YoY EBITDA Growth for the fiscal year that ended in Sep. 2020 is calculated as:

YoY EBITDA Growth (A: Sep. 2020 )
=(EBITDA per Share (A: Sep. 2020 )-EBITDA per Share (A: Sep. 2019 ))/ | EBITDA per Share (A: Sep. 2019 ) |
=(-0.11--0.087)/ | -0.087 |
=-26.44 %

hear.com NV's YoY EBITDA Growth for the quarter that ended in Mar. 2021 is calculated as:

YoY EBITDA Growth (Q: Mar. 2021 )
=(EBITDA per Share (Q: Mar. 2021 )-EBITDA per Share (Q: Dec. 2019 )) / | EBITDA per Share (Q: Dec. 2019 )) |
=(-0.047--0.03)/ | -0.03 |
=-56.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of -56.67% mean?
hear.com NV (HCG) has a YoY EBITDA Growth of -56.67% as of Mar. 2021. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for hear.com NV and its competitors.
Is hear.com NV's YoY EBITDA Growth too high?
hear.com NV's current YoY EBITDA Growth is -56.67%.
How does hear.com NV's YoY EBITDA Growth compare to ?
hear.com NV's YoY EBITDA Growth of -56.67% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Medical Devices & Instruments company?
A good YoY EBITDA Growth depends on the Medical Devices & Instruments industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for hear.com NV and its competitors. hear.com NV's current YoY EBITDA Growth is -56.67%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is hear.com NV stock overvalued right now?
hear.com NV (HCG) has a current YoY EBITDA Growth of -56.67%. The current YoY EBITDA Growth is -56.67%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For hear.com NV (HCG), the current YoY EBITDA Growth is -56.67% as of Mar. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

hear.com NV Business Description

Comparable Companies
hear.com NV is a global leader in the hearing aid industry, It provides the most comprehensive care for all your hearing needs.